alendronate has been researched along with menaquinone 6 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (85.71) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, Y | 1 |
| Ishii, J | 1 |
| Koida, M | 1 |
| Matsumoto, T | 1 |
| Akiyama, Y; Hara, K; Kobayashi, M | 1 |
| Shiraki, M | 2 |
| Sato, S | 1 |
| Hagino, H | 1 |
| Ando, W; Hashimoto, J; Hirao, M; Ono, T; Yoshikawa, H | 1 |
| Soen, S | 1 |
| Kuroda, T; Miyakawa, N; Miyazaki, T; Shiraki, M | 1 |
| Kamo, K; Kasukawa, Y; Maekawa, S; Miyakoshi, N; Noguchi, H; Sasaki, H; Shimada, Y | 1 |
| Fukushima, Y; Hamada, M; Nakase, T; Suzuki, K; Tomita, T; Tsuji, S; Yoshikawa, H | 1 |
8 review(s) available for alendronate and menaquinone 6
| Article | Year |
|---|---|
[Advancement of treatment for osteoporosis].
Topics: Alendronate; Bone Density; Cholecalciferol; Clinical Trials as Topic; Estrogen Replacement Therapy; Etidronic Acid; Fractures, Bone; Humans; Hydroxycholecalciferols; Osteoporosis; Raloxifene Hydrochloride; Vitamin K 2 | 2002 |
[Comparative analyses on osteoporosis guidelines in Japan, EU and USA].
Topics: Alendronate; Calcitonin; Clinical Trials as Topic; Drug Approval; Estriol; Etidronic Acid; Europe; Humans; Isoflavones; Japan; Osteoporosis; Practice Guidelines as Topic; Raloxifene Hydrochloride; United States; Vitamin K 2 | 2002 |
[Pharmacotherapy of osteoporosis].
Topics: Alendronate; Androgens; Animals; Binding Sites; Bone Remodeling; Clinical Trials as Topic; Estrogen Replacement Therapy; Estrogens; Estrogens, Non-Steroidal; Evidence-Based Medicine; Humans; Isoflavones; Osteoblasts; Osteoclasts; Osteoporosis; Phytoestrogens; Plant Preparations; Selective Estrogen Receptor Modulators; Vitamin D; Vitamin K 2 | 2002 |
[New guideline for the treatment of osteoporosis].
Topics: Alendronate; Calcitonin; Calcium; Estrogen Replacement Therapy; Etidronic Acid; Evidence-Based Medicine; Humans; Meta-Analysis as Topic; Osteoporosis; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risedronic Acid; Selective Estrogen Receptor Modulators; Vitamin D; Vitamin K 2 | 2004 |
[Secondary osteoporosis. Evidence of treatment efficacy in patients with glucocorticoid-induced osteoporosis].
Topics: Alendronate; Bone Density Conservation Agents; Calcitonin; Cholecalciferol; Etidronic Acid; Evidence-Based Medicine; Glucocorticoids; Humans; Osteoporosis; Randomized Controlled Trials as Topic; Risedronic Acid; Vitamin K 2 | 2007 |
[Combination therapy for osteoporosis].
Topics: Alendronate; Bone Density Conservation Agents; Calcitonin; Calcium; Cholecalciferol; Diphosphonates; Drug Therapy, Combination; Humans; Osteoporosis; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vitamin K 2 | 2007 |
[Drug therapy of secondary osteoporosis: glucocorticoid-induced osteoporosis].
Topics: Alendronate; Bone Density Conservation Agents; Cholecalciferol; Clinical Trials as Topic; Diphosphonates; Glucocorticoids; Humans; Osteoporosis; Practice Guidelines as Topic; Spinal Fractures; Vitamin K 2 | 2009 |
[A-TOP research group/JOINT program].
Topics: Alendronate; Bone Density Conservation Agents; Cholecalciferol; Drug Therapy, Combination; Evidence-Based Medicine; Fractures, Bone; Fractures, Spontaneous; Humans; Japan; Multicenter Studies as Topic; Osteoporosis; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Societies, Medical; Vitamin K 2 | 2009 |
2 trial(s) available for alendronate and menaquinone 6
| Article | Year |
|---|---|
[A head-to-head comparative study for evaluation of effectiveness among drugs for osteoporosis].
Topics: Aged; Alendronate; Bone and Bones; Bone Density; Bone Density Conservation Agents; Drug Evaluation; Etidronic Acid; Fractures, Spontaneous; Humans; Hydroxycholecalciferols; Osteoporosis; Vitamin K 2 | 2006 |
Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women.
Topics: 1-Carboxyglutamic Acid; Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Carboxylic Acids; Drug Therapy, Combination; Female; Femur Neck; Humans; Osteocalcin; Postmenopause; Prospective Studies; Vitamin K 2 | 2008 |
4 other study(ies) available for alendronate and menaquinone 6
| Article | Year |
|---|---|
Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet.
Topics: Alendronate; Alkaline Phosphatase; Animals; Body Weight; Bone and Bones; Bone Density; Calcitriol; Calcium; Elasticity; Femur; Hydroxyproline; Magnesium; Magnesium Deficiency; Male; Osteocalcin; Parathyroid Hormone; Rats; Rats, Wistar; Stress, Mechanical; Urine; Vitamin K 2 | 2004 |
[Very old patients with osteoporosis should be treated with alendronate].
Topics: Age Factors; Aged; Aged, 80 and over; Alendronate; Bone Density; Bone Density Conservation Agents; Bone Resorption; Cholecalciferol; Cohort Studies; Female; Follow-Up Studies; Humans; Osteoporosis, Postmenopausal; Retrospective Studies; Spinal Fractures; Vitamin K 2 | 2006 |
Effects of combination treatment with alendronate and vitamin K(2) on bone mineral density and strength in ovariectomized mice.
Topics: Alendronate; Animals; Biomechanical Phenomena; Body Weight; Bone Density; Bone Density Conservation Agents; Female; Femur; Mice; Mice, Inbred C57BL; Osteoporosis; Ovariectomy; Vitamin K 2 | 2010 |
Clinical results of alendronate monotherapy and combined therapy with menatetrenone (VitK₂) in postmenopausal RA patients.
Topics: Aged; Alendronate; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Prospective Studies; Treatment Outcome; Vitamin K 2 | 2013 |